Organization | University of Saskatchewan

University of Saskatchewan Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4

Founded: Saskatoon Canada (1907)

Organization Overview

First Clinical Trial

1995

NCT00005776

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2023

Timeline

NOW

Now

Alternative names

College of Pharmacy & Nutrition, University of Saskatchewan | Department of Anesthesia, University of Saskatchewan, Canada | Department of Anesthesiology, Perioperative Medicine and Pain Management, University of Saskatchewan | Department of Anesthesiology, University of Saskatchewan | Department of Medicine University of Saskatchewan | Dept OB/GYN, University of Saskatchewan | Don Cockcroft | Dr.Hani Jawa | Dr.Jennifer Jones | Dr.Wael El-matary | Jim Pattison Children's Hospital Foundation | Mela, Mansfield, M.D. | Royal University Hospital, Saskatoon, Saskatchewan | Royal University Hospital, Saskatoon, Saskatchewan, Canada | Saskatchewan Cancer Agency | Saskatoon Cancer Center | School Of Rehabilitation Science, University Of Saskatchewan | University of Saskatchewan | University of Saskatchewan College of Medicine | University of Saskatchewan, Department of Anesthesia | University of Saskatchewan, Department of Anesthesiology, Perioperative Medicine, and Pain Management | University of Saskatchewan, Department of Medicine, Division of Cardiology | University of Saskatchewan, Department of Medicine, Division of Hematology | University of Saskatchewan, Department of Medicine, Division of Respirology, Critical Care and Sleep Medicine | University of Saskatchewan, Department of Pediatrics, Head of Neonatal Research Group | University of Saskatchewan, Dept. of Obstetrics and Gynecology | University of Saskatchewan, Dept. of Obstetrics and Gynecology, College of Medicine | University of Saskatchewan, Saskatoon, SK,Canada | University of Saskatchew Full Professor | U of S Department of Anesthesiology, Perioperative Medicine and Pain Management

Active Ingredients

Drugs in Phase 4 Trials (41)

albuterol (proventil) (3 trials)

apixaban (eliquis) (1 trial)

budesonide (rhinocort) (1 trial)

cetirizine (zyrtec) (1 trial)

cetrorelix (cetrotide) (1 trial)

cyclosporine (sandimmune) (1 trial)

desloratadine (clarinex) (2 trials)

dexmedetomidine (precedex) (4 trials)

diphenhydramine (benadryl) (1 trial)

ethinyl estradiol (Estinyl) (3 trials)

fentanyl (Innovar) (4 trials)

fludeoxyglucose f-18 (1 trial)

fluticasone (cutivate) (2 trials)

follitropin alfa (Gonal-F) (1 trial)

glycopyrronium (robinul) (2 trials)

human choriogonadotropin alfa (hCG) (1 trial)

inactivated influenza vaccine (1 trial)

indacaterol (arcapta neohaler) (1 trial)

ipratropium (atrovent) (2 trials)

ketamine (ketalar) (7 trials)

lamotrigine (lamictal) (1 trial)

letrozole (femara) (2 trials)

lutropin alpha (luveris) (1 trial)

mannitol (Osmitrol) (3 trials)

metformin (glucophage) (1 trial)

methacholine (provocholine) (5 trials)

mrna-1273 (Spikevax) (1 trial)

mycophenolate (CellCept) (1 trial)

naproxen (naprosyn) (1 trial)

norgestrel (Ovral) (1 trial)

oxytocin (syntocinon) (1 trial)

prednisone (meticorten) (1 trial)

propofol (diprivan) (2 trials)

quetiapine (seroquel) (1 trial)

ropivacaine (naropin) (3 trials)

salmeterol (serevent) (1 trial)

sodium chloride (7 trials)

tacrolimus (prograf) (1 trial)

thiamine (1 trial)

tiotropium (spiriva) (4 trials)

vilanterol (Anoro Elipta) (1 trial)

Drugs in Phase 3 Trials (19)

acetaminophen (tylenol) (2 trials)

creatine (5 trials)

dexamethasone (2 trials)

diazoxide (hyperstat) (1 trial)

flax (2 trials)

Ga 68 PSMA-11 (Illuccix) (1 trial)

gabapentin (neurontin) (2 trials)

levobupivacaine (chirocaine) (1 trial)

lidocaine (xylocaine) (6 trials)

linolic acid (1 trial)

magnesium sulfate (Tis-U-Sol) (1 trial)

midazolam (versed) (1 trial)

misoprostol (cytotec) (1 trial)

nitric oxide (inomax) (1 trial)

ondansetron (zofran) (3 trials)

sevoflurane (ultane) (2 trials)

sufentanil (1 trial)

tranexamic acid (cyklokapron) (3 trials)

Drugs in Phase 2 Trials (21)

bevacizumab (avastin) (1 trial)

carboplatin (paraplatin) (2 trials)

covac-2 (3 trials)

cpg-odn (1 trial)

docetaxel (taxotere) (1 trial)

etonogestrel (1 trial)

fluorouracil (efudex) (2 trials)

gemcitabine (gemzar) (1 trial)

irinotecan (Camptosar) (2 trials)

leucovorin (2 trials)

linseed oil (1 trial)

methadone (methadose) (1 trial)

nimotuzumab (2 trials)

nivolumab (opdivo) (1 trial)

oxaliplatin (eloxatin) (1 trial)

paclitaxel (taxol) (1 trial)

secoisolariciresinol (3 trials)

selenite (1 trial)

tezepelumab (Tezspire) (1 trial)

vitamin d3 (2 trials)

whey protein (3 trials)

Drugs in Phase 1 Trials (6)

amino acids (Freamine) (1 trial)

bupivacaine (Exparel) (2 trials)

cannimed (1 trial)

covac-1 (2 trials)

estradiol (progynon depot) (1 trial)

ulipristal (ella) (1 trial)

Drugs in Other Trials (24)

albumin (Human) (Plasbumin) (1 trial)

beta-alanine (1 trial)

blood plasma (1 trial)

bovine colostrum (2 trials)

caffeine (1 trial)

chlorhexidine (hibitane) (1 trial)

dark chocolate (1 trial)

desogestrel (Mercilon) (2 trials)

glucose monohydrate (1 trial)

helium (1 trial)

hemp powder (1 trial)

honey (2 trials)

hydroxyethyl starch (voluven) (1 trial)

ibuprofen (motrin) (2 trials)

lentil (1 trial)

maltodextrin (3 trials)

melatonin (1 trial)

montelukast (singulair) (1 trial)

oxygen (1 trial)

propranolol (inderal) (1 trial)

ringer's lactate (1 trial)

soybean (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Acute Coronary Syndrome (Phase 4)

Adenocarcinoma (Phase 2)

Angina, Unstable (Phase 4)

Anorexia (Phase 1)

Anorexia Nervosa (Phase 1)

Arsenic Poisoning (Phase 2)

Asthma (Phase 4)

Bipolar Disorder (Phase 4)

Brain Diseases (Phase 1)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Cardiovascular Diseases (Phase 4)

Colitis (Phase 2)

Colitis, Ulcerative (Phase 2)

Colorectal Neoplasms (Phase 2)

Coronary Artery Disease (Phase 3)

Crohn Disease (Phase 2)

Delirium (Phase 4)

Dementia (Phase 2)

Depression (Phase 4)

Depressive Disorder (Phase 4)

Depressive Disorder, Major (Phase 4)

Depressive Disorder, Treatment-Resistant (Phase 4)

Diabetic Nephropathies (Phase 4)

Drug-Related Side Effects and Adverse Reactions (Phase 4)

Emergencies (Phase 4)

Epilepsy (Phase 1)

Esophageal Neoplasms (Phase 2)

Fetal Macrosomia (Phase 3)

Fractures, Bone (Phase 4)

Hemorrhage (Phase 4)

Hip Fractures (Phase 4)

Hypersensitivity (Phase 2)

Hypertension (Phase 3)

Hypertension, Pulmonary (Phase 3)

Hypoglycemia (Phase 3)

Infant, Newborn, Diseases (Phase 3)

Infertility (Phase 4)

Inflammation (Phase 3)

Influenza, Human (Phase 4)

Labor Pain (Phase 1)

Lung Neoplasms (Phase 2)

Menorrhagia (Phase 3)

Metabolic Syndrome (Phase 3)

Muscle Weakness (Phase 3)

Osteoporosis (Phase 3)

Pain, Postoperative (Phase 4)

Pathologic Processes (Phase 3)

Persistent Fetal Circulation Syndrome (Phase 3)

Pneumonia (Phase 3)

Pneumonia, Aspiration (Phase 3)

Poisoning (Phase 2)

Postoperative Complications (Phase 3)

Postoperative Hemorrhage (Phase 3)

Postpartum Hemorrhage (Phase 4)

Pregnancy, Ectopic (Phase 1)

Pregnancy in Diabetics (Phase 3)

Prostatic Neoplasms (Phase 3)

Pulmonary Valve Insufficiency (Phase 3)

Respiratory Aspiration (Phase 3)

Respiratory Distress Syndrome (Phase 3)

Respiratory Distress Syndrome, Newborn (Phase 3)

Respiratory Hypersensitivity (Phase 4)

Respiratory Insufficiency (Phase 3)

Sarcopenia (Phase 3)

Sleep Apnea, Obstructive (Phase 3)

Sleep Apnea Syndromes (Phase 3)

Syndrome (Phase 3)

Tissue Adhesions (Phase 1)

Ulcer (Phase 2)

Uterine Inertia (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 110
# of Trial APIs: 111